Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2025-12-24 @ 7:58 PM
NCT ID:
NCT05211804
Eligibility Criteria:
Inclusion Criteria:
* Patients have to be 18 years or older
* Newly diagnosed nAMD (group 1) or nAMD treatment for at least 1 year (group 2), both with typical neovascular findings on OCT-A
* Patients with acceptable travel distance to the hospital
* Patients accepting to be part of the study
Exclusion Criteria:
* Other non-AMD macular disorders
* A spherical equivalent of -6 diopters or less
* Opacities of the visual axis; Changes of the cornea, anterior chamber, lens or vitreous cavity causing image acquisition artefacts
* Patients not able to attend extra controls due to age, illnesses or other factors
* Contraindications of intraocular injection therapy; Active ocular or periocular infection, active and serious intraocular inflammation, hypersensitivity to the drug or recent stroke / heart attack
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05211804
Study Brief:
Protocol Section:
NCT05211804